Candel Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

CADL

organization

SIC: 2836

SEC Insider

$51.5M

236 transactions

Summary

Candel Therapeutics, Inc. (CADL) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $25.6MSales: $4.4M20 insiders

Date	Insider	Type	Value
2026-02-23	Manning Paul B	Buy	$3.0M
2026-03-31	Manning Paul B	A	$19K
2026-03-31	PAPA JOSEPH C	A	$11K
2026-03-31	Loggia Nicoletta	A	$3K
2025-07-28	Nichols William Garrett(Chief Medical Officer)	M	$1K
2026-06-23	PAPA JOSEPH C	A	$0
2026-06-23	Manning Paul B	A	$0
2026-06-23	Benz Edward J. JR	A	$0
2026-06-23	Gaeta Renee	A	$0
2026-06-23	Nguyen Diem	A	$0
2026-06-23	Nabel Gary J.	A	$0
2026-06-23	Martell Christopher	A	$0
2026-06-23	Loggia Nicoletta	A	$0
2026-06-23	Radhakrishnan Maha	A	$0
2026-01-26	Barone Francesca(Chief Scientific Officer)	A	$0
2026-01-26	Tak Paul Peter(Chief Executive Officer)	A	$0
2026-01-26	Schoch Charles(Chief Financial Officer)	A	$0
2026-01-26	Nichols William Garrett(Chief Medical Officer)	A	$0
2026-01-26	Tyagarajan Seshu(Chief Technology Officer)	A	$0
2025-07-28	Nichols William Garrett(Chief Medical Officer)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Candel Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope